101
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Breast cancer risk in a rapidly aging population: advances and approaches to study the aging tissue microenvironment

Pages 111-113 | Published online: 19 Feb 2019

References

  • KaruturiMVanderWaldeNMussHApproach and management of breast cancer in the elderlyClin Geriatr Med201632113315326614865
  • DittmerJMechanisms governing metastatic dormancy in breast cancerSemin Cancer Biol201744728228344165
  • BraunSVoglFDNaumeBA pooled analysis of bone marrow micrometastasis in breast cancerN Engl J Med2005353879380216120859
  • SmithBDJiangJMcLaughlinSSImprovement in breast cancer outcomes over time: are older women missing out?J Clin Oncol201129354647465322067407
  • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)ClarkeMCoatesASAdjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trialsLancet20083719606294018177773
  • LyratzopoulosGAbelGABrownCHSocio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancerAnn Oncol201324384385023149571
  • OwusuCLashTLSillimanRAEffect of undertreatment on the disparity in age-related breast cancer-specific survival among older womenBreast Cancer Res Treat2007102222723617004115
  • DiabSGElledgeRMClarkGMTumor characteristics and clinical outcome of elderly women with breast cancerJ Natl Cancer Inst200092755055610749910
  • DaidoneMGCoradiniDMartelliGVeneroniSPrimary breast cancer in elderly women: biological profile and relation with clinical outcomeCrit Rev Oncol Hematol200345331332512633842
  • López-OtínCBlascoMAPartridgeLSerranoMKroemerGThe hallmarks of agingCell201315361194121723746838
  • ShiozawaYEberMRBerryJETaichmanRSBone marrow as a metastatic niche for disseminated tumor cells from solid tumorsBonekey Rep2015468926029360
  • PlaceAEJin HuhSPolyakKThe microenvironment in breast cancer progression: biology and implications for treatmentBreast Cancer Res201113622722078026
  • EmensLABreast cancer immunotherapy: facts and hopesClin Cancer Res201824351152028801472
  • EmensLAKokMOjalvoLSTargeting the programmed cell death-1 pathway in breast and ovarian cancerCurr Opin Obstet Gynecol201628214214726881392
  • BonafèMStorciGFranceschiCInflamm-aging of the stem cell niche: breast cancer as a paradigmatic example: breakdown of the multi-shell cytokine network fuels cancer in aged peopleBioessays2012341404922086861
  • EmensLAAsciertoPADarcyPKCancer immunotherapy: opportunities and challenges in the rapidly evolving clinical landscapeEur J Cancer20178111612928623775
  • EmensLABreast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockadeExpert Rev Anticancer Ther201212121597161123253225
  • Cimino-MathewsAFooteJBEmensLAImmune targeting in breast cancerOncology201529537538525979549
  • ChiriacVFBabanADumitrascuDLPsychological stress and breast cancer incidence: a systematic reviewClujul Med2018911182629440947
  • StraubRHCutoloMPsychoneuroimmunology-developments in stress researchWien Med Wochenschr20181683–4768428600777
  • CroneMHallmanKLloydVThe antiestrogenic effects of black cohosh on BRCA1 and steroid receptors in breast cancer cellsBreast Cancer (Dove Med Press) In press2019
  • OzdemirBZGoodinJBBodennerDLBreast cancer prevention in older women: an algorithm to choose an optimal preventive agentBreast Cancer (Dove Med Press) In press2019
  • TremmelEHofmannSKuhnCThyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migrationBreast Cancer (Dove Med Press) In press2019
  • AyoubNMAl-ShamiKMYaghanRJImmunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approachesBreast Cancer (Dove Med Press)201911536930697064